We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

This study is currently recruiting participants.
Verified February 2017 by Pawel Kalinski, University of Pittsburgh
Sponsor:
ClinicalTrials.gov Identifier:
NCT01545141
First Posted: March 6, 2012
Last Update Posted: February 3, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Hemispherx Biopharma
Information provided by (Responsible Party):
Pawel Kalinski, University of Pittsburgh
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)